CCNE1 and cancer: Furthermore, MAGE-C2 is involved in increasing cyclin E stability and cell cycle progression by inhibiting ubiquitin-mediated degradation of cyclin E. Our results suggest that MAGE-C2 may promote proliferation of cancer cells at least in part through protecting the protein stability of cyclin E.